Creatine Nootropic Stacks: What Works and What Is Marketing
Creatine monohydrate is the most heavily researched compound sitting anywhere near the nootropic shelf, and almost nobody sells it as one. It lives in the sports aisle in a plain white tub for a few pounds a month at the time of writing, while brightly branded focus blends often charge several times as much for ingredients with a fraction of the human data behind them. If you are trying to build a sensible stack for mental work rather than collecting capsules, the honest version is short: creatine has the deepest research base and the most credible mechanism, citicoline has a smaller but real body of trials, caffeine works but comes with trade-offs, and most of what surrounds those three in a typical nootropic blend is dosing theatre. Here is the evidence, including the parts that do not flatter creatine.
Creatine is the nootropic nobody labels as one
The reason creatine keeps appearing in brain research is bioenergetic. Creatine and phosphocreatine act as a rapid buffer for ATP, the cell's energy currency, and neurons are among the most energy-hungry cells in the body. If you can nudge the size of that buffer in the brain, the theory goes, you may change how the brain copes when energy demand spikes or supply falls short.
That first step is reasonably well established. Using magnetic resonance spectroscopy, Dechent and colleagues in 1999 gave six healthy volunteers 4 x 5 g of creatine monohydrate a day for four weeks and measured a statistically significant rise of about 8.7% in mean total brain creatine, with wide individual variation. Later work has broadly agreed that brain creatine does respond to oral creatine, but by a smaller margin than the rise seen in skeletal muscle. The brain guards its own creatine pool more tightly than muscle does.
The best known early cognitive trial is Rae and colleagues in 2003, published in Proceedings of the Royal Society B. Forty-five young vegetarian adults took 5 g of creatine a day for six weeks in a double-blind crossover design, and the researchers reported significant improvements in backward digit span and Raven's Advanced Progressive Matrices. That study is where a lot of the "creatine makes you smarter" internet lore originates.
Worth saying plainly before we go further: in Great Britain and the EU, the authorised health claims for creatine are about exercise, not thinking. The permitted wording in the GB nutrition and health claims register, mirrored in the EU register, is that creatine increases physical performance in successive bursts of short-term, high intensity exercise, and it may only be used for foods providing a daily intake of 3 g of creatine. A second authorised claim covers creatine taken with regular resistance training and muscle strength in adults over 55. Everything below about cognition is published research, discussed as research, and not a claim about what any product will do for you.
What the brain research shows, and where it stops
Pooled analyses have found signal, but a modest and uneven one.
A 2023 meta-analysis in Nutrition Reviews by Prokopidis and colleagues reported that creatine improved measures of memory versus placebo in healthy individuals, with the clearest effects in older adults aged 66 to 76 and essentially nothing in participants aged 11 to 31. A 2024 systematic review and meta-analysis in Frontiers in Nutrition pooled 16 randomised controlled trials and 492 participants, reporting significant effects on memory, attention time and processing speed time, with no significant effect on overall cognitive function or executive function. Certainty of evidence was rated moderate for memory and low to very low for everything else. That paper has since been issued a corrigendum, although it fixed two wording errors rather than the analysis and the authors state the conclusions are unchanged. The fragility is in the inputs, not the correction: 492 participants spread across six outcome domains is a thin base to build on.
Two other pieces of evidence keep the enthusiasm honest:
- McMorris and colleagues, 2024, in Behavioural Brain Research concluded that while creatine supplementation does raise brain creatine content, the results for cognition are equivocal, and that supplementation protocols in this literature need fixing.
- Sandkühler and colleagues, 2023, in BMC Medicine ran one of the larger trials, 123 adults on 5 g a day for six weeks, and found only a small potential benefit. Backward digit span was borderline at p = 0.064, equivalent to roughly 2.5 IQ points, and Raven's matrices did not reach significance at p = 0.327. Their own framing was that the effect is much smaller than previously claimed.
Then there is the regulator. In November 2024 the EFSA panel published an unfavourable opinion on a proposed creatine and cognitive function health claim, having assessed the 21 human intervention studies put forward by the applicant. Among its observations: the acute effects reported at high doses were not seen at lower intakes or with continuous consumption, and the proposed condition of use was 3 g a day.
That dose point is the single most useful thing in this whole article. The most striking recent brain study, Gordji-Nejad and colleagues, 2024, in Scientific Reports, gave 15 young adults a single dose of 0.35 g per kg of body weight during 21 hours of enforced wakefulness. That is roughly 25 g for a 70 kg adult. They observed changes in cerebral high energy phosphates and better processing speed and working memory versus placebo. It is a genuinely interesting result, and it is a laboratory dose used once under sleep deprivation, not a daily habit. Anyone quoting that study to sell you a 1 g capsule is quoting it dishonestly.
So the fair summary of creatine as a nootropic: strong mechanism, real but small and inconsistent cognitive findings in rested healthy people, and the most promising signals in people who are stressed, sleep deprived or older. The intuitive idea that vegetarians and vegans must respond more, because they start from lower dietary creatine, is plausible but not well supported. Sandkühler's team deliberately recruited roughly half vegetarians and found no indication that they benefited more than omnivores. If you are weighing intake against dosing, the loading phase question is worth reading up on.
Creatine for studying: what is reasonable to expect
If you are searching for creatine for studying, calibrate first. Creatine is not a stimulant. Nothing happens 30 minutes after a scoop. It works by gradually saturating a storage pool over days to weeks, which is why when you take it matters far less than whether you take it every day. Judged honestly over a few weeks, the plausible upside in the research is a small edge on working memory and processing speed, most likely to show up when you are tired or under load, and least likely to show up when you are well rested and well fed. It is not a substitute for sleep, and the sleep deprivation research is arguably the best argument for how much sleep matters in the first place.
What pairs sensibly with creatine
Citicoline
Citicoline, also called CDP-choline, is a compound the body uses in the synthesis of phosphatidylcholine, a major structural component of cell membranes, and it also serves as a source of choline. There are no authorised UK health claims for citicoline, so what follows is published research and nothing more.
Two trials get cited most often. McGlade and colleagues, 2012, in Food and Nutrition Sciences, randomised 60 healthy women aged 40 to 60 to 250 mg, 500 mg or placebo for 28 days. Both citicoline groups made significantly fewer commission errors on the Continuous Performance Test II than placebo, and the 250 mg group also made significantly fewer omission errors, while the 500 mg group fell short of significance on that particular measure. Nakazaki and colleagues, 2021, in The Journal of Nutrition gave 500 mg a day for 12 weeks to 100 adults aged 50 to 85 with age-associated memory impairment, and reported significantly greater improvement in episodic memory on a paired associate test versus placebo, 0.15 versus 0.06, P = 0.0025.
Read those with appropriate scepticism. Many citicoline trials use a single branded ingredient and are funded by its manufacturer, and healthy adults in their twenties and thirties are under-represented. It is a smaller and thinner literature than creatine's. If you want the dose reasoning, see citicoline dosage, the comparison with other choline forms, and why the creatine and citicoline pairing makes sense on paper.
Caffeine, with the trade-offs stated
Caffeine is the one ingredient in this category where the acute effect is not seriously disputed. In 2011 the EFSA panel concluded that a cause and effect relationship had been established between caffeine and increased alertness, for servings providing at least 75 mg. When an applicant later asked for that threshold to be lowered to 40 mg, the panel declined and restated the 75 mg figure. Worth knowing that the claim was never actually authorised for use in Great Britain or the EU, so no product may carry it on a label. The trade-offs are equally well documented: tolerance builds, it has a long half-life that can erode sleep quality, and it can amplify anxiety in people prone to it.
On combining it with creatine, the origin of the worry is Vandenberghe and colleagues, 1996, in the Journal of Applied Physiology, who found caffeine appeared to counteract the ergogenic benefit of creatine loading in nine men. That result has not been convincingly replicated, and the review by Trexler and Smith-Ryan in 2015 concluded the evidence that caffeine meaningfully impairs creatine at normal supplementation doses is weak. Practical version in our creatine and caffeine post: the interaction is not the thing to worry about, your total caffeine load and your sleep are.
The unglamorous layer
Sleep, protein intake, and resistance training move cognitive performance more than any capsule in this article. A stack that ignores them is a stack built to be sold rather than to work.
Quick comparison of common stack ingredients
| Ingredient | Human evidence in healthy adults | Dose used in research | Common marketing overreach |
|---|---|---|---|
| Creatine monohydrate | Largest base of any ingredient here; cognitive effects small and inconsistent, clearest under sleep loss and in older adults | 3 to 5 g daily; brain studies often 20 g or more short term | Citing a 25 g single-dose sleep deprivation study to sell a 1 g capsule |
| Citicoline | Several RCTs on attention and memory, mostly in women aged 40 to 60 and adults over 50 | 250 to 500 mg daily, 4 to 12 weeks | Implying instant focus, or blending in doses far below the trials |
| Caffeine | Strong and immediate; EFSA judged the alertness effect established at 75 mg or more, though the claim is not authorised for label use | 75 to 200 mg acute | Selling tolerance-building stimulation as cognitive enhancement |
| Bacopa monnieri | Mixed; a 2014 meta-analysis of nine RCTs found faster Trail B and choice reaction times, other trials null | Around 300 mg standardised extract, 12 weeks or more | Sold as fast-acting when trials run three months |
| Lion's mane | Limited and inconsistent; an acute RCT in healthy younger adults found no significant effect on overall cognition or mood | No settled effective dose | Preclinical nerve growth factor findings presented as human outcomes |
| Ginkgo biloba | A systematic review of trials in healthy people found no convincing cognitive effect under 60; Cochrane found no convincing evidence of efficacy in dementia and cognitive impairment | 120 to 240 mg daily | Still marketed as a memory herb decades after the evidence stalled |
What is mostly marketing in nootropic blends
Proprietary blends. If a label lists twelve ingredients inside a single named "matrix" with one total weight, you cannot tell how much of anything you are getting. The industry itself is blunt about why this persists: proprietary blends are widely used as camouflage for fairy dusting, meaning trace amounts of expensive actives listed for label appeal. There is no synergy argument that justifies hiding the numbers.
The arithmetic problem. This one you can check yourself without any expertise. A researched daily dose of creatine is 3 to 5 g, which is roughly a teaspoon of powder and, depending on capsule size, roughly four to seven standard capsules on its own. So any capsule product listing creatine alongside ten other ingredients in a 1 g blend is mathematically incapable of delivering a researched creatine dose. The same logic applies to citicoline at 250 to 500 mg. Add up the label. Most focus blends fail on the first ingredient.
Ingredients carried by preclinical data. Cell and rodent studies are how research starts, not how it ends. When the human trials in healthy adults are absent, small, or null, the marketing tends to lean harder on mechanism language such as neurogenesis, neuroplasticity and nerve growth factor. That is a tell, not a credential.
Things that should not be in a food supplement. Racetams are the clearest example. Piracetam is a prescription only medicine in the UK, licensed for adults with myoclonus of cortical origin and used alongside other anti-myoclonic therapies, and it is not a permitted food supplement ingredient. If a site sells it to you as a nootropic, that tells you what else on the site to distrust.
Unregulated vocabulary. "Nootropic" is a marketing word, not a regulated category, and "clinically studied" can honestly mean one small industry-funded trial on a single ingredient at a dose the product does not contain.
How to build a simple honest stack
- Creatine monohydrate, 3 to 5 g, every day. Unflavoured monohydrate is the researched form and the cheapest. Consistency beats timing. If you want the safety literature rather than the forum consensus, start with is creatine safe.
- Optionally citicoline at a dose that matches the trials, 250 to 500 mg, and give it 4 to 12 weeks before forming any opinion.
- Caffeine only if you already tolerate it, at a steady dose, kept well away from bedtime.
- Nothing you cannot name and count. If the label will not tell you the milligrams, that is your answer.
- Assess honestly. Track something real over a month or two, such as focused work sessions or training performance, and be willing to conclude it did nothing for you.
That principle is why we built perco as one stick of 5 g creatine monohydrate plus 300 mg citicoline with the amounts printed openly, rather than a twelve-ingredient blend. It is not on sale yet. The waitlist is open at percocreatine.com, and founding members lock in founding-member pricing.
Frequently asked questions
Is creatine a nootropic? By the loose definition used in supplement marketing, yes: it is a compound studied for effects on cognitive performance, and it has more human research behind it than most ingredients sold explicitly as nootropics. By regulatory standards, no. EFSA rejected a creatine and cognition health claim in 2024, and the authorised GB claims concern physical performance in successive bursts of short-term, high intensity exercise at 3 g a day, plus muscle strength in adults over 55 who also do regular resistance training.
Does creatine help with studying or exam revision? The research does not support promising that. What it shows is small and inconsistent effects on memory and processing speed in rested healthy adults, with clearer signals in sleep-deprived participants and in older adults. It is a slow-building daily habit rather than something to take the night before an exam.
Can I take creatine and citicoline together? There is no known interaction between them, and they are studied for different reasons: creatine for cellular energy buffering, citicoline for membrane phospholipid synthesis and as a choline source. No trial has tested the combination for cognitive outcomes, so nobody, including us, can honestly claim synergy. We cover the reasoning in creatine and citicoline together.
Do I need more than 5 g of creatine for brain benefits? Some researchers argue that higher intakes are needed to move brain creatine meaningfully, since the brain increase is smaller than the muscle increase, and the most striking cognitive study used about 25 g in a single dose. That is an open research question, not settled advice. Higher intakes are not established as necessary or appropriate for daily use, and 3 to 5 g remains the standard studied maintenance intake.
Is a pre-made nootropic blend ever worth buying? Only if it prints every dose and those doses match the trials it references. Once you check the arithmetic, most blends cannot fit a researched dose of even one bulky ingredient, let alone eight. Buying two or three ingredients separately at full doses is almost always cheaper and always more transparent.
Strong body. Clear mind.
A daily creatine + citicoline sachet, made in the UK. Founding members get the first batch first.
Join the waitlist